Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wunderlich

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2005
AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansionJames C Mulloy, Vladimir Jankovic, Mark Wunderlich, et al.
Haematologica|April 29, 2021
LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemiaGabriel Gracia-Maldonado, Jason Clark, Matthew Burwinkel, et al.
Blood|February 17, 2012
The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETOFu-Sheng Chou, Andrea Griesinger, Mark Wunderlich, et al.
Experimental Hematology|May 22, 2020
Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitroXiaofei He, Aixia Dou, Saran Feng, et al.
Experimental Hematology|March 26, 2026
Development of Hematopoietic Stem Cell-targeted LNPs through Lipid Composition OptimizationTakamasa Hiraki, Keita Yamamoto, Yu-Hsuan Chang, et al.
Leukemia|August 2, 2023
Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitorCuiqing Fan, Mark Wunderlich, Xiongwei Cai, et al.
Blood|August 6, 2017
The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiationBenjamin Mizukawa, Eric O'Brien, Daniel C Moreira, et al.
Blood|March 6, 2015
MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemiaJayeeta Roychoudhury, Jason P Clark, Gabriel Gracia-Maldonado, et al.
Blood|September 24, 2011
Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemiaBenjamin Mizukawa, Junping Wei, Mahesh Shrestha, et al.
Nature Communications|July 9, 2020
Publisher Correction: MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemiaSvetlana S Itskovich, Arun Gurunathan, Jason Clark, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2005
AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansionJames C Mulloy, Vladimir Jankovic, Mark Wunderlich, et al.
Haematologica|April 29, 2021
LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemiaGabriel Gracia-Maldonado, Jason Clark, Matthew Burwinkel, et al.
Blood|February 17, 2012
The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETOFu-Sheng Chou, Andrea Griesinger, Mark Wunderlich, et al.
Experimental Hematology|May 22, 2020
Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitroXiaofei He, Aixia Dou, Saran Feng, et al.
Experimental Hematology|March 26, 2026
Development of Hematopoietic Stem Cell-targeted LNPs through Lipid Composition OptimizationTakamasa Hiraki, Keita Yamamoto, Yu-Hsuan Chang, et al.
Leukemia|August 2, 2023
Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitorCuiqing Fan, Mark Wunderlich, Xiongwei Cai, et al.
Blood|August 6, 2017
The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiationBenjamin Mizukawa, Eric O'Brien, Daniel C Moreira, et al.
Blood|March 6, 2015
MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemiaJayeeta Roychoudhury, Jason P Clark, Gabriel Gracia-Maldonado, et al.
Blood|September 24, 2011
Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemiaBenjamin Mizukawa, Junping Wei, Mahesh Shrestha, et al.
Nature Communications|July 9, 2020
Publisher Correction: MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemiaSvetlana S Itskovich, Arun Gurunathan, Jason Clark, et al.
Pageof 12